Occurrence of ras mutations in human lung cancer. Minireview - PubMed

Affiliations

• PMID: 9372854

Review

Occurrence of ras mutations in human lung cancer. Minireview

J Vachtenheim. Neoplasma. 1997.

Abstract

Members of ras family of oncogenes, when activated by a point mutation, have been implicated in many types of human cancers. In several types of human solid tumors, point mutations of the K-ras gene are relatively frequent. Among lung cancers, a subset of non-small cell lung carcinomas, mostly adenocarcinomas, contains activated K-ras. The examination of K-ras mutations in samples obtained for diagnostic reasons, such as bronchial biopsies or bronchoalveolar lavage fluid, may be used as a supplement in the early diagnosis of lung adenocarcinoma.

Similar articles

• Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.

  Vachtenheim J, Horáková I, Novotná H, Opáalka P, Roubková H. Vachtenheim J, et al. Clin Cancer Res. 1995 Mar;1(3):359-65. Clin Cancer Res. 1995. PMID: 9815992

• K-ras activation in non-small cell lung cancer in the dog.

  Kraegel SA, Gumerlock PH, Dungworth DL, Oreffo VI, Madewell BR. Kraegel SA, et al. Cancer Res. 1992 Sep 1;52(17):4724-7. Cancer Res. 1992. PMID: 1324792

• Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung.

  Rodenhuis S, van de Wetering ML, Mooi WJ, Evers SG, van Zandwijk N, Bos JL. Rodenhuis S, et al. N Engl J Med. 1987 Oct 8;317(15):929-35. doi: 10.1056/NEJM198710083171504. N Engl J Med. 1987. PMID: 3041218

• ras oncogenes in human cancer: a review.

  Bos JL. Bos JL. Cancer Res. 1989 Sep 1;49(17):4682-9. Cancer Res. 1989. PMID: 2547513 Review.

• K-ras mutation: early detection in molecular diagnosis and risk assessment of colorectal, pancreas, and lung cancers--a review.

  Minamoto T, Mai M, Ronai Z. Minamoto T, et al. Cancer Detect Prev. 2000;24(1):1-12. Cancer Detect Prev. 2000. PMID: 10757118 Review.

Cited by

• Prx I suppresses K-ras-driven lung tumorigenesis by opposing redox-sensitive ERK/cyclin D1 pathway.

  Park YH, Kim SU, Lee BK, Kim HS, Song IS, Shin HJ, Han YH, Chang KT, Kim JM, Lee DS, Kim YH, Choi CM, Kim BY, Yu DY. Park YH, et al. Antioxid Redox Signal. 2013 Aug 10;19(5):482-96. doi: 10.1089/ars.2011.4421. Epub 2013 Jun 13. Antioxid Redox Signal. 2013. PMID: 23186333 Free PMC article.

• Overproduction of reactive oxygen species - obligatory or not for induction of apoptosis by anticancer drugs.

  Ivanova D, Zhelev Z, Aoki I, Bakalova R, Higashi T. Ivanova D, et al. Chin J Cancer Res. 2016 Aug;28(4):383-96. doi: 10.21147/j.issn.1000-9604.2016.04.01. Chin J Cancer Res. 2016. PMID: 27647966 Free PMC article.

• Parthenium hysterophorus: a probable source of anticancer, antioxidant and anti-HIV agents.

  Kumar S, Chashoo G, Saxena AK, Pandey AK. Kumar S, et al. Biomed Res Int. 2013;2013:810734. doi: 10.1155/2013/810734. Epub 2013 Nov 17. Biomed Res Int. 2013. PMID: 24350290 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Medical

  • MedlinePlus Health Information

• Miscellaneous

  • NCI CPTAC Assay Portal